Surfacine Development Co. granted patent for user-applied anti-microbial coating
BOSTON -- Surfacine Development Co. LLC has been issued U. S. Patent No. 6,180,584 for composition of matter for its dispensable anti-microbial technology. This is the first patent issued for Surfacine, for use in consumer products, that
provides a residual anti-microbial effect.
This patent shows that Surfacine can be added to a variety of hospital-grade and consumer products including hard-surface disinfectants and cleaners as well as skin antiseptics, sanitizers, protectants, liquid wound dressings or bandages. The technology may be used for treating skin-contacting articles -- such as diapers, wound dressings, wipes, and surgical masks and gowns -- and non-body contacting articles -- such as hospital bed rails, carpets and rugs -- providing such
products with a sustained biocidal effect.